June 2018

June 29, 2018

The rise of ID pharmacy as a profession has been complementary to services uniquely offered by ID physicians, not in competition with them.

June 29, 2018

Although challenging, it is not impossible to change some outlier behaviors.

June 29, 2018

The updated guidelines recommend targeting those with active infection and avoiding treatment of “carriers” of C difficile who are colonized but not symptomatic.

June 28, 2018

Experts continue to recommend that people get the seasonal flu vaccine as the scientific community works toward a universal vaccine offering lifelong protection against multiple strains.

June 28, 2018

MJH Associates, Inc & the FDA are both committed to eliminating inefficiencies and hype to deliver the most timely and relevant information to health care providers.

June 28, 2018

Preliminary studies provide convincing evidence for the synergistic use of sulfonamide agents with azole antifungals.

June 28, 2018

Because of the global rise in antimicrobial resistance, meropenem-vaborbactam, the first carbapenem/β-lactamase combina­tion medication, is a welcome new antibac­terial.

June 26, 2018

Early diagnosis and treatment were essential to ensuring a good prognosis.

June 25, 2018

The emergence of new species creates pressure for developing affordable and reliable diagnostic strategies.

June 22, 2018

Patient and institutional history, as well as the individual niches of the new antibiotics, need to be considered when selecting a treatment for gram-negative infections.

June 21, 2018

Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.

June 20, 2018

Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.

June 19, 2018

An increase in injection drug use in the United States has augmented the likelihood of acquiring HCV, particularly genotype 3.